We tested this idea, first by transducing NES cells with MYCN and second by deriving NES cells from patients with Gorlin syndrome, bearing germline mutations in PTCH1, and in each case performing orthotopic transplantation in mice. This evidence concerns the gene MYCN and nevoid basal cell carcinoma syndrome.